Aeolus Pharmaceuticals, Inc.

OTCPK:AOLS Stock Report

Market Cap: US$152.0

Aeolus Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

John Mcmanus

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure19.4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure11.5yrs

Recent management updates

No updates

Recent updates


CEO

John Mcmanus (60 yo)

19.4yrs

Tenure

US$497,715

Compensation

Mr. John L. McManus has been the Chief Executive Officer of Aeolus Pharmaceuticals Inc., since March 2007 and as its President June 20, 2005. Mr. McManus is the Founder of McManus Financial Consultants, In...


Board Members

NamePositionTenureCompensationOwnership
Chris Rallis
Director20.4yrsUS$20.98kno data
Mitchell Kaye
Director11.5yrsno datano data
John Farah
Independent Director19.1yrsUS$20.98kno data
Jeffrey Scott
Director11.5yrsUS$15.74kno data
John Clerici
Director11.5yrsUS$15.74kno data

11.5yrs

Average Tenure

66yo

Average Age

Experienced Board: AOLS's board of directors are seasoned and experienced ( 11.5 years average tenure).